tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Flaten, 108 are a BUY (97.3%), 3 are a HOLD (2.7%).
Analyst Thomas Flaten, currently employed at LAKE STREET, carries an average stock price target met ratio of 39.67% that have a potential upside of 53.94% achieved within 158 days.
Thomas Flaten’s has documented 210 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BLFS, BioLife Solutions at 22-Jul-2026.
Analyst best performing recommendations are on ENSC (ENSYSCE BIOSCIENCES).
The best stock recommendation documented was for ENSC (ENSYSCE BIOSCIENCES) at 12/1/2021. The price target of $14400 was fulfilled within 8 days with a profit of $9108 (172.11%) receiving and performance score of 215.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Sep-2024
$13
$6.62 (103.76%)
$13
3 months 27 days ago
(23-Jun-2026)
0/4 (0%)
$7.99 (159.48%)
Buy Since 21-Aug-2025
$12
$5.98 (99.34%)
$12
3 months 28 days ago
(22-Jun-2026)
0/5 (0%)
$6.9 (135.29%)
Buy Since 23-Jun-2021
$11
$4.98 (82.72%)
$11
1 years 10 months 16 days ago
(04-Dec-2024)
0/7 (0%)
$6.47 (142.83%)
Buy Since 16-Apr-2024
$20
$13.98 (232.23%)
$20
2 years 10 days ago
(10-Oct-2024)
0/3 (0%)
$15.05 (304.04%)
Buy Since 17-Sep-2020
$11
$4.62 (72.41%)
$19
2 years 7 months 15 days ago
(04-Mar-2024)
0/5 (0%)
$6.61 (150.57%)
Which stock is Thomas Flaten most bullish on?
Which stock is Thomas Flaten most reserved on?
What Year was the first public recommendation made by Thomas Flaten?
